Medtronic, Inc. (MDT) Reports In-Line Q4 EPS; Guides FY15

Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.58 billion.

Medtronic, Inc. sees FY2015 EPS of $4.00-$4.10, versus the consensus of $4.09. In fiscal year 2015, the company expects full-year revenue growth in the range of 3 to 5 percent on a constant currency basis.

For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist